insurance companies News
Most Popular insurance companies Story
Strong Phase III data for J&J's psoriasis drug
Centocor, a Johnson & Johnson company, announced promising Phase III results for ustekinumab (CNTO 1275), a treatment for Read more...
Latest Headlines
- May 14, 2008
- October 4, 2007
- August 16, 2007
- January 23, 2007
- January 2, 2007
- October 25, 2006
- October 15, 2006
- August 23, 2006
- August 17, 2006
- June 28, 2006
- June 21, 2006
- February 14, 2006
- October 16, 2005
- September 26, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
